Securities Code: 300482 Bond Code: 123064 Securities Abbreviation: Wanfu Bio Bond Abbreviation: Wanfu Convertible Bond Announcement No.: 2026-029 Guangzhou Wanfu Biotechnology Co., Ltd. Announcement on Confirmation of Remuneration for Directors and Senior Management in 2025 and Remuneration Standards for 2026
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or major omissions.
I. Confirmation of Remuneration for Directors and Senior Management in 2025
In accordance with the "Articles of Association" of Guangzhou Wanfu Biotechnology Co., Ltd. (hereinafter referred to as the "Company"), combined with the actual situation of the Company's business development and referencing industry and regional remuneration levels, the Company has confirmed the remuneration payment situation for directors and senior management in 2025. This was reviewed and approved at the 23rd meeting of the Fifth Board of Directors held on April 22, 2026. The relevant situation is announced as follows:
According to calculations, the pre-tax remuneration of the Company's directors and senior management in 2025 is as follows:
Unit: Ten Thousand Yuan